Partnership with DXY, the largest Chinese physician portal
MDLinx, a division of M3 USA, and DXY, the largest physician portal in China, announced an agreement granting MDLinx exclusive access to their physician panel for international pharmaceutical market research.
The new agreement, announced at the ESOMAR Global Healthcare Conference, enables market researchers seamless access to more than 350,000 verified Chinese physicians.
DXY will provide the verified panel and in-country project management.
MDLinx will provide its patented technology and best practices in market research from its PRC certified staff.
The total global reach for MDLinx now exceeds 1,000,000 healthcare professionals worldwide in the top pharmaceutical markets including the USA, G5, Japan, South Korea, and now China.
China is the fastest emerging market and on pace to be the 5th largest global pharmaceutical market in 2010. “We are excited to partner with MDLinx and join together with the global leader in international physician panel.” said Stanley Li, MD, PhD, and founder of DXY, “Our in-country expertise and unsurpassed reach partnered with the MDLinx’s staff and technology creates the best solution for worldwide pharmaceutical market researchers to access China”
“Now clients can access the fastest growing market in the world using the same US based project management team they have used for years,” said William Hoover, Director of Market Research at MDLinx, “We are dedicated to giving our clients what they need the most - a one stop shop for the highest quality, best priced panel in the world.”
For more information contact:
Karie Eastburn
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
New York, NY - March 2, 2010
|
